RU2017111649A - Парентеральные композиции и их применение - Google Patents

Парентеральные композиции и их применение Download PDF

Info

Publication number
RU2017111649A
RU2017111649A RU2017111649A RU2017111649A RU2017111649A RU 2017111649 A RU2017111649 A RU 2017111649A RU 2017111649 A RU2017111649 A RU 2017111649A RU 2017111649 A RU2017111649 A RU 2017111649A RU 2017111649 A RU2017111649 A RU 2017111649A
Authority
RU
Russia
Prior art keywords
composition
composition according
injection
representative
paragraphs
Prior art date
Application number
RU2017111649A
Other languages
English (en)
Other versions
RU2744987C2 (ru
RU2017111649A3 (ru
Inventor
Флоранс ГЕМБЕРТО
Анн ГЕНЕТО
Жером ГИЙОНЕ
Original Assignee
Сева Сантэ Анималь
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сева Сантэ Анималь filed Critical Сева Сантэ Анималь
Publication of RU2017111649A publication Critical patent/RU2017111649A/ru
Publication of RU2017111649A3 publication Critical patent/RU2017111649A3/ru
Application granted granted Critical
Publication of RU2744987C2 publication Critical patent/RU2744987C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Claims (10)

1. Парентеральная ветеринарная композиция, содержащая нестероидное противовоспалительное средство, антибиотик и не менее 35% диметилсульфооксида.
2. Композиция по п. 1, в которой нестероидное противовоспалительное средство происходит из семейства оксикамов, предпочтительно выбрано из мелоксикама, пироксикама или теноксикама, в частности, мелоксикама.
3. Композиция по п. 1 или 2, в которой антибиотик выбран из антибиотиков фениколы, в частности, из хлорамфеникола, триамфеникола и флорфеникола, в частности, флорфеникола.
4. Композиция по любому из предыдущих пунктов, которая содержит, по меньшей мере, иной растворитель, в частности, по меньшей мере, иной апротонный полярный растворитель, предпочтительно глицеринформаль.
5. Композиция по любому из предыдущих пунктов, которая предназначена для впрыскивания инъецирования не относящемуся к человеку млекопитающему, в частности, домашнему или выращиваемому животному.
6. Композиция по п. 5, где указанным животным является представитель крупного рогатого скота, свинья, овца, представитель семейства псовых или кошачьих, в частности, представитель крупного рогатого скота.
7. Композиция по п. 5, где инъекция производится внутримышечно или подкожно.
8. Композиция по любому из пп. 1–4 для лечения нарушений, вызванных микробными инфекциями, у не относящихся к человеку млекопитающих, в частности, путём инъекции с использованием названной композиции.
9. Композиция по п. 8, где нарушения, вызванные микробными инфекциями, являются расстройствами или болезнями респираторного характера, поражающими нижние или верхние дыхательные пути.
10. Набор ветеринарного назначения, содержащий композицию, охарактеризованную по любому из пп. 1–9, и, при необходимости, по меньшей мере, один компартмент для стерильной обработки.
RU2017111649A 2014-09-09 2015-09-09 Парентеральные композиции и их применение RU2744987C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14306385.7A EP2995297A1 (fr) 2014-09-09 2014-09-09 Compositions parentérales et leurs utilisations
EP14306385.7 2014-09-09
PCT/EP2015/070539 WO2016038059A1 (fr) 2014-09-09 2015-09-09 Compostions parentérales et leurs utilisations

Publications (3)

Publication Number Publication Date
RU2017111649A true RU2017111649A (ru) 2018-10-10
RU2017111649A3 RU2017111649A3 (ru) 2019-02-14
RU2744987C2 RU2744987C2 (ru) 2021-03-17

Family

ID=51564609

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2017111649A RU2744987C2 (ru) 2014-09-09 2015-09-09 Парентеральные композиции и их применение

Country Status (15)

Country Link
US (1) US20170304450A1 (ru)
EP (3) EP2995297A1 (ru)
AR (1) AR101786A1 (ru)
AU (1) AU2015314311B2 (ru)
BR (1) BR112016028309B1 (ru)
CA (1) CA2959936C (ru)
DK (1) DK3191080T3 (ru)
ES (1) ES2732039T3 (ru)
HU (1) HUE045174T2 (ru)
MX (1) MX371485B (ru)
PL (1) PL3191080T3 (ru)
PT (1) PT3191080T (ru)
RU (1) RU2744987C2 (ru)
SI (1) SI3191080T1 (ru)
WO (1) WO2016038059A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230155155A (ko) * 2022-05-03 2023-11-10 녹십자수의약품 주식회사 마크로라이드 계열 항생제를 유효성분으로 포함하는 개과 동물의 호흡기 질환의 예방 또는 치료용 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5082863A (en) 1990-08-29 1992-01-21 Schering Corporation Pharmaceutical composition of florfenicol
US20030068339A1 (en) 2001-10-02 2003-04-10 Phoenix Scientific, Inc. Veterinary florfenicol formulation that is syringeable under cold weather conditions
KR20040015623A (ko) 2002-08-13 2004-02-19 대한뉴팜(주) 플로르페니콜을 활성성분으로 함유하는 주사액 조성물
EP1568369A1 (en) * 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
MX2009006714A (es) * 2006-12-19 2009-08-31 Schering Plough Ltd Formulaciones efervescentes de florfenicol para adicion en sistemas de agua potable.
US20110105480A1 (en) 2008-06-24 2011-05-05 Keith Freehauf Pharmaceutical transdermal compositions and method for treating inflammation in cattle
FR2936710B1 (fr) * 2008-10-07 2011-01-07 Ceva Sante Animale Composition veterinaire antiprolactinique destinee aux ruminants
NZ588686A (en) * 2011-01-20 2013-07-26 Bayer New Zealand Ltd Injectable composition comprising an NSAID and an antibiotic in a non-aqueous solvent for treating a microbial infection in a mammary gland

Also Published As

Publication number Publication date
ES2732039T3 (es) 2019-11-20
SI3191080T1 (sl) 2019-09-30
EP3513781A1 (fr) 2019-07-24
WO2016038059A1 (fr) 2016-03-17
BR112016028309A2 (pt) 2017-08-22
AR101786A1 (es) 2017-01-11
RU2744987C2 (ru) 2021-03-17
US20170304450A1 (en) 2017-10-26
RU2017111649A3 (ru) 2019-02-14
EP3191080A1 (fr) 2017-07-19
MX371485B (es) 2020-01-30
PL3191080T3 (pl) 2019-11-29
EP2995297A1 (fr) 2016-03-16
AU2015314311B2 (en) 2020-11-26
HUE045174T2 (hu) 2019-12-30
EP3191080B1 (fr) 2019-03-20
DK3191080T3 (da) 2019-06-24
AU2015314311A1 (en) 2017-03-23
MX2017003019A (es) 2017-05-30
CA2959936C (fr) 2023-03-14
PT3191080T (pt) 2019-06-28
CA2959936A1 (fr) 2016-03-17
BR112016028309B1 (pt) 2021-05-11

Similar Documents

Publication Publication Date Title
CL2008001868A1 (es) Compuestos derivados de n-(2-(hetaril)aril)arilsulfonamidas y n-(2-(hetaril)hetaril)arilsulfonamidas; composicion farmaceutica que comprende a dicho compuesto; y uso para el tratamiento de enfermedades inflamatorias del intestino, enfermedad alergica
CY1117559T1 (el) Ενωση ινδολιου και φαρμακευτικη χρηση αυτου
BR112014005268A2 (pt) compostos de amido como moduladores de ror t e usos dos mesmos
CL2019003270A1 (es) Carboxamidas de octa hidrofenantreno - bis y conjugados de proteína.
CL2008000180A1 (es) Sal tosilato de trans-n-etil-3-fluoro-3-[3-fluoro-4-(pirrolidin-1-ilmetil)fenil]ciclobutanocarboxamida; composicion farmaceutica; y uso para el tratamiento de enfermedades tales como depresion, trastornos del sueno, ansiedad y enfermedades del tracto
CO6660445A2 (es) Compuestos heterocíclicos agonistas del receptor ip
CL2007003192A1 (es) Compuestos derivados de arilamidas sustituidas por tiazol u oxazol; composicion farmaceutica; y uso para el tratamiento de una enfermedad del tracto urinario.
EA201791451A1 (ru) 5-[(пиперазин-1-ил)-3-оксо-пропил]-имидазолидин-2,4-дионовые производные в качестве ингибиторов adamts для лечения остеоартрита
BR112012002524A2 (pt) "composto de fórmula, composição, composição para proteger um animal de uma praga parasítica de invertebrados, métodos para controlar uma praga invertebrada e semente tratada"
UY30640A1 (es) Compuestos
EA201592086A1 (ru) Жирная кислота таллового масла для использования в лечении и кормовые добавки и композиции для животных
MX2019014935A (es) Antagonistas muscarinicos y sus combinaciones para el tratamiento de enfermedades de las vias respiratorias en caballos.
MA54521A (fr) Dérivés d'oxopyridine substitués
EA202190070A1 (ru) Бициклические ингибиторы гистондеацетилазы
CO2017000044A2 (es) Derivado de 2–acilaminotiazol o su sal
DK3432900T3 (da) Mælkesyrebakteriesammensæting til behandling af bakterielle vaginale infektioner forårsaget af gardnerella vaginalis og, hvis de forefindes, samtidige svampeinfektioner
RU2017111649A (ru) Парентеральные композиции и их применение
CR20130401A (es) Composiciones inyectables para la mastitis que comprende un antiinflamatorio no esteroideo (aine) y un antibiótico en un disolvente no acuoso
BR112014011508A2 (pt) utilização de pelo menos uma protease estável em meio ácido, e, aditivo e composição para alimentação animal para aves vacinadas
BR112017016388A2 (pt) cenicriviroc para o tratamento da fibrose
BRPI1009773A2 (pt) "composições para tratar uma condição alérgica ou asmática"
EA201792685A1 (ru) Фармацевтическая композиция для лечения воспалительных изменений прямой кишки
AR074674A1 (es) Combinacion de sustancias activas mejorada que comprende un antibiotico y un farmaco antiinflamatorio no esteroideo (aine)
UY31953A (es) 3-cianopirrolidinil-fenil-oxazolidinonas como agentes antibacterianos
JP1717147S (ja) 猫用遊具